Geode Capital Management
CCEL icon

Geode Capital Management’s Cryo-Cell International CCEL Stock Holding History

Geode Capital Management’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$155K Sell
43,616
-9,553
-18% -$31.8K ﹤0.01% 4006
2025
Q4 		$183K Sell
53,169
-247
-0.5% -$1.03K ﹤0.01% 3935
2025
Q3 		$248K Buy
53,416
+7,585
+17% +$36K ﹤0.01% 3855
2025
Q2 		$238K Buy
45,831
+601
+1% +$3.17K ﹤0.01% 3819
2025
Q1 		$288K Buy
45,230
+5,370
+13% +$39K ﹤0.01% 3735
2024
Q4 		$295K Hold
39,860
– – ﹤0.01% 3769
2024
Q3 		$254K Buy
39,860
+16,203
+68% +$112K ﹤0.01% 3825
2024
Q2 		$180K Buy
23,657
+2,229
+10% +$18.4K ﹤0.01% 3952
2024
Q1 		$160K Buy
21,428
+476
+2% +$2.69K ﹤0.01% 4008
2023
Q4 		$121K Hold
20,952
– – ﹤0.01% 4123
2023
Q3 		$110K Buy
20,952
+1,871
+10% +$10.9K ﹤0.01% 4216
2023
Q2 		$116K Hold
19,081
– – ﹤0.01% 4278
2023
Q1 		$57.6K Hold
19,081
– – ﹤0.01% 4486
2022
Q4 		$80K Sell
19,081
-77
-0.4% -$369 ﹤0.01% 4470
2022
Q3 		$116K Buy
+19,158
New +$118K ﹤0.01% 4505

Other funds holding CCEL

SA
SFI Advisors Montclair, New Jersey $95.2M AUM 23.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $6.53B AUM 20.48% 1-Year Est. Return

Geode Capital Management's CCEL Position: Q1 2026 in Review

Geode Capital Management reduced its Cryo-Cell International (CCEL) stake by 18% in Q1 2026, selling an estimated $31.8K and leaving 43,616 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #4006.

Geode Capital Management first reported a position in CCEL in Q3 2022 and has held it in 15 quarters since. The position peaked at $295K in Q4 2024. 11 funds tracked by Wall St. Rank hold CCEL as of Q1 2026.

  • Geode Capital Management held 43,616 shares of Cryo-Cell International worth $155K as of Q1 2026.
  • Geode Capital Management sold 9,553 Cryo-Cell International shares in Q1 2026, an estimated $31.8K.
  • Cryo-Cell International made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4006 holding.
  • Geode Capital Management first reported a position in Cryo-Cell International in Q3 2022 and has held it in 15 quarters since.
  • Geode Capital Management's Cryo-Cell International position peaked at $295K in Q4 2024.
  • 11 funds tracked by Wall St. Rank held Cryo-Cell International as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.